Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $921.70 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $257.59 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.62 | 2 | $0 (2024) |
| Boston Scientific Corporation | $129.41 | 1 | $0 (2024) |
| Melinta Therapeutics, LLC | $124.40 | 1 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $98.29 | 1 | $0 (2023) |
| Lilly USA, LLC | $97.43 | 1 | $0 (2024) |
| Pulmonx Corporation | $73.96 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.05 | 7 | AstraZeneca Pharmaceuticals LP ($257.59) |
| 2023 | $172.25 | 2 | Actelion Pharmaceuticals US, Inc. ($98.29) |
| 2022 | $124.40 | 1 | Melinta Therapeutics, LLC ($124.40) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $129.41 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $97.43 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $98.29 | General |
| Category: Cardiology | ||||||
| 02/07/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $73.96 | General |
| Category: PULMONOLOGY | ||||||
| 07/28/2022 | Melinta Therapeutics, LLC | Vabomere (Drug) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 610 | 1,514 | $341,195 | $167,962 |
| 2022 | 5 | 238 | 660 | $169,360 | $80,500 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 134 | 441 | $165,816 | $70,847 | 42.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 203 | 571 | $85,650 | $50,463 | 58.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 35 | 222 | $42,180 | $25,994 | 61.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 47 | $13,395 | $5,844 | 43.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 26 | 42 | $7,644 | $3,399 | 44.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 55 | $7,150 | $3,210 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 24 | $3,600 | $1,987 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,000 | $1,636 | 54.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 11 | 11 | $3,300 | $1,178 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,540 | $945.48 | 61.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 24 | 24 | $2,400 | $910.24 | 37.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 24 | 24 | $2,400 | $866.74 | 36.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 24 | 24 | $3,120 | $683.13 | 21.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 80 | 278 | $104,528 | $46,700 | 44.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 101 | 236 | $35,400 | $18,381 | 51.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 23 | 100 | $19,000 | $10,172 | 53.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $5,700 | $3,005 | 52.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 15 | 26 | $4,732 | $2,242 | 47.4% |
About Dr. Juan Rey Mendoza, M.D
Dr. Juan Rey Mendoza, M.D is a Internal Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1649622275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Rey Mendoza, M.D has received a total of $921.70 in payments from pharmaceutical and medical device companies, with $625.05 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($921.70).
As a Medicare-enrolled provider, Rey Mendoza has provided services to 848 Medicare beneficiaries, totaling 2,174 services with total Medicare billing of $248,462. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Weslaco, TX
- Active Since 07/07/2016
- Last Updated 04/28/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649622275
Products in Payments
- BREZTRI (Drug) $125.01
- AREXVY (Drug) $125.00
- TEZSPIRE (Biological) $124.99
- Vabomere (Drug) $124.40
- OPSUMIT (Drug) $98.29
- MOUNJARO (Drug) $97.43
- CHARTIS CATHETER (Device) $73.96
- TRELEGY ELLIPTA (Drug) $15.62
- AIRSUPRA (Drug) $7.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Weslaco
Hector Amaya Chinchilla, M.d, M.D
Internal Medicine — Payments: $5,736
Dionisio Calvo
Internal Medicine — Payments: $4,184
Dr. Claudia Pierson, M.d, M.D
Internal Medicine — Payments: $3,969
Pedro Penalo, Md, MD
Internal Medicine — Payments: $3,559
Dr. Robert Sepulveda, M.d, M.D
Internal Medicine — Payments: $2,673
Jesus Rodriguez Hernandez, M.d, M.D
Internal Medicine — Payments: $2,593